|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6569432B1
(en)
*
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
CA2212846A1
(en)
|
1995-02-24 |
1996-08-29 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
US5773292A
(en)
*
|
1995-06-05 |
1998-06-30 |
Cornell University |
Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
|
|
US6379669B1
(en)
*
|
1995-08-04 |
2002-04-30 |
Akhouri A. Sinha |
Targeting of organs by immunoconjugates
|
|
US20040253246A1
(en)
*
|
1996-02-23 |
2004-12-16 |
Israeli Ron S. |
Prostate-specific membrane antigen and uses thereof
|
|
US6150508A
(en)
*
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6962981B1
(en)
*
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US7381407B1
(en)
*
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
AU9233698A
(en)
*
|
1997-11-22 |
1999-06-17 |
Robert A. Levine |
Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
|
|
IL139700A
(en)
*
|
1998-06-15 |
2005-09-25 |
Altarex Medical Corp |
Immunotherapeutic composition for the treatment of prostate cancer
|
|
JP4531267B2
(ja)
*
|
1999-01-22 |
2010-08-25 |
ザ バーナム インスティチュート |
ホーミングプロアポトーシス結合体およびホーミングプロアポトーシス結合体を使用する方法
|
|
JP4495349B2
(ja)
|
1999-01-28 |
2010-07-07 |
ジェン−プローブ・インコーポレーテッド |
癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列
|
|
US6167297A
(en)
†
|
1999-05-05 |
2000-12-26 |
Benaron; David A. |
Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
|
|
US6278726B1
(en)
*
|
1999-09-10 |
2001-08-21 |
Interdigital Technology Corporation |
Interference cancellation in a spread spectrum communication system
|
|
JP5007409B2
(ja)
*
|
2000-05-08 |
2012-08-22 |
セルデックス リサーチ コーポレーション |
樹状細胞に対するヒトモノクローナル抗体
|
|
US7514078B2
(en)
*
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
IL158969A0
(en)
|
2001-06-01 |
2004-05-12 |
Cornell Res Foundation Inc |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7192586B2
(en)
|
2001-09-20 |
2007-03-20 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
EP1448588A4
(en)
*
|
2001-10-23 |
2006-10-25 |
Psma Dev Company L L C |
ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
|
|
US7771953B2
(en)
|
2003-01-10 |
2010-08-10 |
Millenium Pharmaceuticals, Inc. |
Methods of diagnosing and treating cancer
|
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
|
WO2005094882A1
(en)
*
|
2004-03-03 |
2005-10-13 |
Millennium Pharmaceuticals, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US20070248535A1
(en)
*
|
2005-02-07 |
2007-10-25 |
The Trustees Of Columbia University In The City Of New York |
Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
|
|
EP1851251A2
(en)
|
2005-02-18 |
2007-11-07 |
Medarex, Inc. |
Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
|
|
CA2598522A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen (psma)
|
|
RU2450832C2
(ru)
*
|
2006-10-25 |
2012-05-20 |
Конинклейке Филипс Электроникс Н.В. |
Контрастные вещества для детекции рака предстательной железы
|
|
AU2008302345A1
(en)
*
|
2007-09-19 |
2009-03-26 |
Oncofluor, Inc. |
Method for imaging and treating organs and tissues
|
|
PL2326350T3
(pl)
|
2008-09-08 |
2014-03-31 |
Psma Dev Company L L C |
Związki do zabijania eksprymujących PSMA, opornych na taksan komórek rakowych
|
|
EP3903829B1
(en)
|
2009-02-13 |
2023-05-03 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
|
US10517969B2
(en)
|
2009-02-17 |
2019-12-31 |
Cornell University |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
EP2478110B1
(en)
|
2009-09-16 |
2016-01-06 |
Immunomedics, Inc. |
Class i anti-cea antibodies and uses thereof
|
|
ES2978177T3
(es)
|
2009-12-02 |
2024-09-06 |
Immunomedics Inc |
Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer
|
|
EP2506876B1
(en)
|
2009-12-02 |
2016-10-12 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
|
US20130052194A1
(en)
*
|
2009-12-16 |
2013-02-28 |
The Trustees Of The University Of Pennsylvania |
Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same
|
|
US8679858B2
(en)
|
2011-01-11 |
2014-03-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Lanthanide mass dots: nanoparticle isotope tags
|
|
CA2831572C
(en)
|
2011-05-02 |
2019-11-26 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
EP2771688B1
(en)
|
2011-10-25 |
2018-09-26 |
Memorial Sloan-Kettering Cancer Center |
Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
|
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
|
AU2013302696B9
(en)
|
2012-08-14 |
2018-08-09 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
|
DK2900277T3
(da)
|
2012-12-13 |
2022-04-04 |
Immunomedics Inc |
Doser af immunokonjugater af antistoffer og sn-38 til forbedret effektivitet og reduceret toksicitet
|
|
US11109846B2
(en)
*
|
2014-02-14 |
2021-09-07 |
Memorial Sloan-Kettering Cancer Center |
System and method for providing assessment of tumor and other biological components contained in tissue biopsy samples
|
|
WO2015126548A1
(en)
|
2014-02-21 |
2015-08-27 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to trop-2 expressing cells
|
|
CA2935748A1
(en)
|
2014-02-25 |
2015-09-03 |
Immunomedics, Inc. |
Humanized rfb4 anti-cd22 antibody
|
|
WO2015200260A1
(en)
|
2014-06-24 |
2015-12-30 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
|
JP6678941B2
(ja)
|
2014-10-07 |
2020-04-15 |
イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． |
抗体−薬物コンジュゲートのネオアジュバント使用
|
|
JP6746845B2
(ja)
|
2015-04-22 |
2020-08-26 |
イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． |
循環ｔｒｏｐ−２陽性癌細胞の単離、検出、診断及び／または特徴付け
|
|
CN107849148B
(zh)
|
2015-05-21 |
2023-09-19 |
哈普恩治疗公司 |
三特异性结合蛋白质及使用方法
|
|
WO2016210108A1
(en)
|
2015-06-25 |
2016-12-29 |
Immunomedics, Inc. |
Combining anti-hla-dr or anti-trop-2 antibodies with microtubule inhibitors, parp inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
|
PL3316885T3
(pl)
|
2015-07-01 |
2021-12-06 |
Immunomedics, Inc. |
Immunokoniugaty przeciwciało-sn-38 z linkerem cl2a
|
|
CN108136012B
(zh)
|
2015-08-07 |
2022-10-04 |
伊麦吉纳博公司 |
靶向分子的抗原结合构建体
|
|
LT3461261T
(lt)
|
2016-05-20 |
2025-08-25 |
Harpoon Therapeutics, Inc. |
Vienos grandinės kintamo fragmento cd3 surišantys baltymai
|
|
US10100106B2
(en)
|
2016-05-20 |
2018-10-16 |
Harpoon Therapeutics, Inc. |
Single domain serum albumin binding protein
|
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
|
CA3044729A1
(en)
|
2016-11-23 |
2018-05-31 |
Harpoon Therapeutics, Inc. |
Psma targeting trispecific proteins and methods of use
|
|
WO2018098354A1
(en)
|
2016-11-23 |
2018-05-31 |
Harpoon Therapeutics, Inc. |
Prostate specific membrane antigen binding protein
|
|
US11266745B2
(en)
|
2017-02-08 |
2022-03-08 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
EP3589662A4
(en)
|
2017-02-28 |
2020-12-30 |
Harpoon Therapeutics, Inc. |
INDUCTIBLE MONOVALENT ANTIGEN BINDING PROTEIN
|
|
CN113896792B
(zh)
|
2017-05-12 |
2025-08-22 |
哈普恩治疗公司 |
间皮素结合蛋白质
|
|
EP3621648A4
(en)
|
2017-05-12 |
2021-01-20 |
Harpoon Therapeutics, Inc. |
TRISPECIFIC PROTEINS MSLN AND METHOD OF USE
|
|
KR102425983B1
(ko)
|
2017-10-13 |
2022-07-29 |
하푼 테라퓨틱스, 인크. |
삼중특이적 단백질 및 사용 방법
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
KR20210020903A
(ko)
|
2018-05-14 |
2021-02-24 |
하푼 테라퓨틱스, 인크. |
면역글로불린 분자의 조건부 활성화를 위한 결합 모이어티
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
IL281683B2
(en)
|
2018-09-25 |
2023-04-01 |
Harpoon Therapeutics Inc |
dll3 binding proteins and methods of use
|
|
CA3170833A1
(en)
|
2020-02-21 |
2021-08-26 |
Harpoon Therapeutics, Inc. |
Flt3 binding proteins and methods of use
|
|
RU2757641C1
(ru)
*
|
2021-03-09 |
2021-10-19 |
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) |
Способ лучевой терапии больных раком предстательной железы с метастазами в регионарных лимфатических узлах таза
|
|
US20250073349A1
(en)
|
2021-05-10 |
2025-03-06 |
Kawasaki Institute Of Industrial Promotion |
Antibody having reduced binding affinity for antigen
|